SubHero Banner
Text

May 2023

Core topics in this month’s edition include:

  • Abrysvo (respiratory syncytial virus vaccine) – new vaccine approval
  • Arexvy (respiratory syncytial virus vaccine, adjuvanted) – new vaccine approval
  • Farxiga (dapagliflozin) – expanded indication
  • Veozah (fezolinetant) – new drug approval

Download PDF

Text